Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,746,808 | $2,822,765 | $3,006,798 | $2,671,845 |
| - Cash | $203,400 | $250,100 | $229,300 | $269,500 |
| + Debt | $369,300 | $3,878,500 | $3,863,300 | $3,703,400 |
| Enterprise Value | $2,912,708 | $6,451,165 | $6,640,798 | $6,105,745 |
| Revenue | $821,500 | $826,200 | $776,000 | $864,400 |
| % Growth | -0.6% | 6.5% | -10.2% | – |
| Gross Profit | $195,300 | $195,600 | $161,900 | $233,600 |
| % Margin | 23.8% | 23.7% | 20.9% | 27% |
| EBITDA | $405,400 | $152,000 | $98,200 | $161,000 |
| % Margin | 49.3% | 18.4% | 12.7% | 18.6% |
| Net Income | -$22,700 | -$2,500 | -$37,700 | -$108,500 |
| % Margin | -2.8% | -0.3% | -4.9% | -12.6% |
| EPS Diluted | -0.18 | -0.02 | -0.3 | -0.86 |
| % Growth | -813.7% | 93.4% | 65.1% | – |
| Operating Cash Flow | $83,600 | $81,300 | $6,000 | $111,400 |
| Capital Expenditures | -$19,800 | -$23,400 | -$22,700 | -$22,300 |
| Free Cash Flow | $63,800 | $57,900 | -$16,700 | $89,100 |